The Human Microbiome is the collection of microorganisms and their genetic material associated with the human body, together with the communities and ecological relationships they form. It includes bacteria, archaea, fungi, viruses and other microscopic organisms occupying habitats such as the intestine, oral cavity, skin, respiratory tract and reproductive tract.
The term microbiome is sometimes used specifically for the collective genetic material of these organisms and sometimes more broadly for the organisms and their ecological system, while microbiota more precisely refers to the organisms themselves. Human microbial communities are not distributed uniformly throughout the body. Each anatomical site has distinctive physical and chemical conditions that select for particular microbial populations. Oxygen availability, pH, moisture, nutrient supply, host secretions, immune activity and interactions with neighbouring microorganisms all influence community composition. The human microbiome is therefore dynamic rather than a fixed collection of organisms. It changes with age, diet, environment, medication, disease, physiology and other factors.
The gastrointestinal tract contains one of the most extensively studied human microbial ecosystems. Microorganisms in the intestine participate in fermentation of dietary components that escape digestion in the upper gastrointestinal tract and can produce metabolites such as short chain fatty acids. Different microbial groups specialise in different substrates, and cross feeding allows one organism to consume products generated by another. Microbial metabolism can therefore transform complex dietary compounds into molecules that interact with intestinal cells and the wider host environment.
The intestinal community also competes with incoming microorganisms for nutrients and attachment sites and can influence local chemical conditions. However, claims about specific microbiome effects must be distinguished from associations observed in sequencing studies. Finding that a microbial taxon is more abundant in a particular disease does not establish that the microorganism caused the disease. Experimental studies, mechanistic evidence and appropriate controls are needed to determine causation.
The oral microbiome occupies diverse habitats including teeth, tongue, saliva and mucosal surfaces. Different microbial communities can exist within the same mouth because local oxygen gradients, surfaces, nutrients and host secretions vary. Some microorganisms participate in normal oral ecology without causing disease, while changes in community structure and environmental conditions can contribute to dental caries or periodontal disease. The skin microbiome is similarly shaped by local conditions such as moisture, temperature, lipid availability and exposure to the external environment.
Dry skin sites, moist areas and sebaceous regions support different microbial communities. Microorganisms can interact with host immune mechanisms and with one another, and their presence can contribute to colonisation resistance against some external organisms. These examples demonstrate that the human microbiome is best understood as multiple interconnected microbial ecosystems rather than one uniform community distributed throughout the body.
The human microbiome develops and changes across the lifespan. Early microbial colonisation is influenced by environmental exposure, feeding patterns, contact with caregivers and other factors. Microbial communities then change as diet, physiology, hormonal state, behaviour and environmental exposure change. In later life, medications, illness and changes in diet or immune function can alter microbial composition. Antibiotics can produce substantial shifts by suppressing susceptible bacteria and allowing resistant or intrinsically less susceptible organisms to increase in relative abundance.
Some communities may recover towards their previous composition after treatment, whereas others can undergo longer lasting changes. The degree of recovery depends on the drug, treatment duration, baseline community, host factors and subsequent exposures. This dynamic behaviour is one reason why microbiome research often studies trajectories over time rather than relying on a single sample.
Human microbiome research uses a range of molecular and analytical techniques. Culture based microbiology can identify organisms that grow under selected laboratory conditions, but many microorganisms are difficult to culture or require specific environments. Sequencing of marker genes can estimate the composition of microbial communities, while shotgun metagenomic sequencing provides broader information about microbial genes and can sometimes support strain level analysis.
Metatranscriptomics examines microbial RNA and can provide information about expressed genes, while metabolomics measures chemical compounds present in biological samples. These approaches have different strengths and limitations. DNA detection does not necessarily prove that an organism is alive or metabolically active, and relative abundance data can change because one population expands or contracts rather than because another population changes absolutely. Sample collection, storage, extraction methods, sequencing depth, database quality and bioinformatic pipelines can influence results. Careful experimental design is therefore essential for reliable interpretation.
The human microbiome has been investigated in relation to numerous aspects of health and disease, including gastrointestinal disorders, inflammatory conditions, metabolic disorders, oral disease and infections. Some studies identify statistical associations between particular microbial configurations and disease states, while experimental work seeks mechanisms that could explain those associations. Microbial metabolites, immune interactions, competition and modification of dietary compounds are among the mechanisms under investigation.
However, the field has historically faced challenges involving small cohorts, confounding variables, inconsistent definitions of healthy microbiomes and difficulty distinguishing cause from consequence. A microbial change observed during disease may result from the disease, its treatment, altered diet or other environmental changes rather than initiating the condition. Consequently, microbiome research increasingly emphasises longitudinal studies, controlled interventions and mechanistic experiments.
The microbiome also has practical relevance to medicine through approaches intended to modify microbial communities. Faecal microbiota transplantation is an established clinical intervention for recurrent Clostridioides difficile infection in appropriate circumstances, where transfer of a donor derived microbial community can restore ecological functions disrupted by disease or treatment. Other microbiome directed approaches include selected probiotics, prebiotics, defined microbial consortia and dietary interventions, although evidence varies considerably among conditions and products.
The term probiotic should not be treated as synonymous with any microorganism associated with health, because probiotic effects are specific to strains and formulations. Microbiome based therapeutics also require attention to safety, donor screening, manufacturing consistency and long term ecological effects. Future approaches may use defined communities rather than complex donor material and may engineer microorganisms to perform particular functions.
The human microbiome has major implications for understanding humans as biological systems because microbial genes substantially expand the biochemical capabilities present within the human body. Humans and their microorganisms interact through nutrient exchange, metabolic transformation, immune signalling and ecological competition. Nevertheless, popular descriptions sometimes exaggerate the simplicity or certainty of these relationships. There is no single ideal human microbiome shared identically by everyone, and microbial composition naturally varies among individuals and body sites.
Diversity alone is not necessarily a direct measure of health, because functional consequences depend on which organisms and genes are present and what they are doing. Likewise, the presence of a particular microbial species does not automatically imply either benefit or disease. Modern human microbiome research therefore focuses increasingly on function, mechanisms, strain level variation, host context and longitudinal change. The field integrates microbiology, genomics, ecology, immunology, nutrition and medicine to investigate how microbial communities contribute to human biology and how their activities might be safely understood or modified.
